Pictet Asset Management Holding Sa Regeneron Pharmaceuticals, Inc. Transaction History
Pictet Asset Management Holding Sa
- $88.9 Billion
- Q4 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 214,097 shares of REGN stock, worth $153 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
214,097
Previous 286,545
25.28%
Holding current value
$153 Million
Previous $301 Million
49.37%
% of portfolio
0.17%
Previous 0.34%
Shares
6 transactions
Others Institutions Holding REGN
# of Institutions
1,487Shares Held
85.7MCall Options Held
1.53MPut Options Held
1.43M-
Vanguard Group Inc Valley Forge, PA9.29MShares$6.62 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.02 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$5.04 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.45 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$3.38 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $76.5B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...